Global Syndromic Multiplex Diagnostic Market Report (2022 to 2027) – Increasing Demand for Accurate and Rapid Results is Driving Growth – ResearchAndMarkets.com

Global Syndromic Multiplex Diagnostic Market Report (2022 to 2027) – Increasing Demand for Accurate and Rapid Results is Driving Growth – ResearchAndMarkets.com




Global Syndromic Multiplex Diagnostic Market Report (2022 to 2027) – Increasing Demand for Accurate and Rapid Results is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Syndromic Multiplex Diagnostic Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering.

The syndromic multiplex diagnostic market is anticipated to grow with a CAGR of nearly 7.2% during the forecast period.

Companies Mentioned

  • BIOMERIEUX SA
  • Qiagen
  • Luminex Corporation
  • Applied BioCode
  • Akonni Biosystems
  • Mesa Biotech
  • Abbott Laboratories
  • Accelerate Diagnostic
  • Diagenode Diagnostics
  • Hologic, Inc.

Key Market Trends

Respiratory Syndrome is Expected to Hold the Major Market Share in the Syndromic Multiplex Diagnostic Market

Respiratory syndromes account for the largest share of the syndromic multiplex diagnostics market and expected to continue the same throughout the forecast period. This dominance mainly due to factors such as the higher demand due to the rapid spread of infections along with the launch of new products with USFDA approvals in the segment that contributes to its major revenue share in the global market.

By End-user, hospitals account for the largest share due to the availability of all resources at a single facility. Also, the reduction of the overall stay of patients for treatment in hospitals with the reduced procedural time along with minimal or no uncertainties, and errors in the treatments is expected to fuel the market during the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America has been the primary market for the syndromic multiplex diagnostic market and is expected to hold a significant share in global revenue owing to the adoption of advanced technologies and the availability of improved healthcare infrastructure, and also rise in R&D laboratories resultant.

Globally, the syndromic multiplex diagnostics market is expected to witness the fastest growth in Asia-Pacific region during the forecast period due to the higher demand for treatments with widespread infections, rise in government support to spread the healthcare awareness among people about various infections in the region.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Demand for Accurate and Rapid Results

4.2.2 Quick Access to the Treatment and Reduction of the Adverse Reactions of Antibiotics

4.3 Market Restraints

4.3.1 Reluctance by Doctors and lack of Skilled Professional

4.3.2 Inability in Detecting Asymptomatic Cases

4.4 Porter’s Five Force Analysis

5 MARKET SEGMENTATION

5.1 By Type of Syndrome

5.1.1 Respiratory

5.1.2 Gastrointestinal

5.1.3 Central Nervous System

5.1.4 Others

5.2 By End-user

5.2.1 Hospitals

5.2.2 Diagnostics Laboratories

5.2.3 Others

5.3 Geography

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 BIOMERIEUX SA

6.1.2 Qiagen

6.1.3 Luminex Corporation

6.1.4 Applied BioCode

6.1.5 Akonni Biosystems

6.1.6 Mesa Biotech

6.1.7 Abbott Laboratories

6.1.8 Accelerate Diagnostic

6.1.9 Diagenode Diagnostics

6.1.10 Hologic, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/sln8rn

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900